Pexelizumab

Modify Date: 2024-04-09 16:33:12

Pexelizumab structure	Common Name	Pexelizumab
	CAS Number	219685-93-5	Molecular Weight	N/A
	Density	N/A	Boiling Point	N/A
	Molecular Formula	N/A	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Pexelizumab

Pexelizumab (h5G1. 1-SC) is a humanized scFv monoclonal antibody directed against the C5 complement component. Pexelizumab inhibits apoptosis and leukocyte infiltration. Pexelizumab can be used for the research of cerebral IR injury and myocardial infarction[1][2].

Name	h5G1.1-scFv

Description	Pexelizumab (h5G1. 1-SC) is a humanized scFv monoclonal antibody directed against the C5 complement component. Pexelizumab inhibits apoptosis and leukocyte infiltration. Pexelizumab can be used for the research of cerebral IR injury and myocardial infarction[1][2].
Related Catalog	Signaling Pathways >> Apoptosis >> Apoptosis Research Areas >> Cardiovascular Disease Signaling Pathways >> Immunology/Inflammation >> Complement System Research Areas >> Neurological Disease
In Vitro	Pexelizumab (h5G1. 1-SC) 抑制 5G1.1 单抗的结合，IC50 为 1.5 nM[2]。
References	[1]. APEX AMI Investigators, et al. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA. 2007 Jan 3;297(1):43-51. [2]. Thomas TC, et al. Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv. Mol Immunol. 1996 Dec;33(17-18):1389-401.

No Any Chemical & Physical Properties

Pexelizumab

Use of Pexelizumab

Names

Pexelizumab Biological Activity

Chemical & Physical Properties